These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8670337)
1. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Zhang Y; Gripenberg-Lerche C; Söderström KO; Toivanen A; Toivanen P Arthritis Rheum; 1996 Jul; 39(7):1238-43. PubMed ID: 8670337 [TBL] [Abstract][Full Text] [Related]
2. Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin. Zhang Y; Toivanen A; Toivanen P Br J Rheumatol; 1997 May; 36(5):541-6. PubMed ID: 9189055 [TBL] [Abstract][Full Text] [Related]
3. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response. Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042 [TBL] [Abstract][Full Text] [Related]
4. Yersinia-associated arthritis in the rat: experimental model for human reactive arthritis? Toivanen A; Merilahti-Palo R; Gripenberg C; Lahesmaa-Rantala R; Söderström KO; Jaakkola UM Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):261-9. PubMed ID: 3495095 [TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Hoogkamp-Korstanje JA; Moesker H; Bruyn GA Ann Rheum Dis; 2000 Nov; 59(11):914-7. PubMed ID: 11053072 [TBL] [Abstract][Full Text] [Related]
6. Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA. Di Genaro MS; Cargnelutti DE; Castro DO; Eliçabe RJ; Gutiérrez JV; Correa SG; de Guzmán AM Scand J Rheumatol; 2007; 36(1):28-35. PubMed ID: 17454932 [TBL] [Abstract][Full Text] [Related]
7. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Hill JL; Yu DT Infect Immun; 1987 Mar; 55(3):721-6. PubMed ID: 3493220 [TBL] [Abstract][Full Text] [Related]
8. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis. Appel H; Mertz A; Distler A; Sieper J; Braun J J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678 [TBL] [Abstract][Full Text] [Related]
9. Persistent Yersinia enterocolitica infection in three rat strains. Curfs JH; Meis JF; Van der Lee HA; Mulder JA; Kraak WA; Hoogkamp-Korstanje JA Microb Pathog; 1995 Jul; 19(1):57-63. PubMed ID: 8559041 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response. Mertz AK; Ugrinovic S; Lauster R; Wu P; Grolms M; Böttcher U; Appel H; Yin Z; Schiltz E; Batsford S; Schauer-Petrowski C; Braun J; Distler A; Sieper J Arthritis Rheum; 1998 Feb; 41(2):315-26. PubMed ID: 9485090 [TBL] [Abstract][Full Text] [Related]
11. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Granfors K; Merilahti-Palo R; Luukkainen R; Möttönen T; Lahesmaa R; Probst P; Märker-Hermann E; Toivanen P Arthritis Rheum; 1998 May; 41(5):855-62. PubMed ID: 9588737 [TBL] [Abstract][Full Text] [Related]
12. Long term follow up of SHR rats with experimental yersinia associated arthritis. Merilahti-Palo R; Gripenberg-Lerche C; Söderström KO; Toivanen P Ann Rheum Dis; 1992 Jan; 51(1):91-6. PubMed ID: 1540047 [TBL] [Abstract][Full Text] [Related]
13. Treatment of arthritis in Lewis rats by a monoclonal antibody against alpha beta T cell receptor: differential sensitivity of Yersinia-induced arthritis versus adjuvant arthritis. Gaede K; Nazet M; Bosse D; Hünig ; Heesemann J Clin Immunol Immunopathol; 1995 Dec; 77(3):339-48. PubMed ID: 7586745 [TBL] [Abstract][Full Text] [Related]
14. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Sieper J; Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Hiepe F; Alten R; Keitel W; Groh A; Uksila J; Eggens U; Granfors K; Braun J Arthritis Rheum; 1999 Jul; 42(7):1386-96. PubMed ID: 10403266 [TBL] [Abstract][Full Text] [Related]
16. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis. Alanärä T; Aittomäki S; Kuuliala K; Kuuliala A; Siitonen S; Leirisalo-Repo M; Repo H Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550 [TBL] [Abstract][Full Text] [Related]
17. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. Heesemann J; Gaede K; Autenrieth IB APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822 [TBL] [Abstract][Full Text] [Related]
18. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Yli-Kerttula T; Luukkainen R; Yli-Kerttula U; Möttönen T; Hakola M; Korpela M; Sanila M; Parviainen J; Uksila J; Vainionpää R; Toivanen A Ann Rheum Dis; 2000 Jul; 59(7):565-70. PubMed ID: 10873968 [TBL] [Abstract][Full Text] [Related]
19. Synovial T cell proliferation to the Yersinia enterocolitica 19 kDa antigen differentiates yersinia triggered reactive arthritis (ReA) from ReA triggered by other enterobacteria. Appel H; Rudwaleit M; Wu P; Grolms M; Sieper J; Mertz A Ann Rheum Dis; 2002 Jun; 61(6):566-7. PubMed ID: 12006341 [No Abstract] [Full Text] [Related]